Physician profile

Deborah A Lozito

Internal Medicine · Hawthorne, NJ

NPI 1134251945

$2,950.49

in general payments reported to CMS, 2019-2025

36 companies · $292 in 2025

The $292 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,127.41

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $733.47 2019-2025 Ozempic, Rybelsus, Wegovy
Astellas Pharma US INC $411.95 2019-2025 Veozah
Merck Sharp & Dohme LLC $196.66 2019-2025 Gardasil 9, Capvaxive, Gardasil
Pfizer INC. $176.23 2019-2024
Allergan, INC. $130.32 2020
Lilly USA, LLC $126.92 2020-2025 Mounjaro, Jardiance
Astrazeneca Pharmaceuticals LP $120.39 2019-2024 Airsupra, Lokelma
Glaxosmithkline, LLC. $117.55 2021-2025 Trelegy Ellipta, Shingrix, Arexvy
Abbvie INC. $98.69 2021-2023
Exact Sciences Corporation $81.55 2023-2024 Cologuard Collection Kit
Boehringer Ingelheim Pharmaceuticals, INC. $77.58 2019-2023 Jardiance
Amarin Pharma, INC. $56.77 2019-2021
Myovant Sciences INC. $53.59 2022
Genentech USA, INC. $43.78 2020-2021
Amgen INC. $42.65 2020-2021
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Topcon Healthcare Solutions, INC. $42.34 2021
Esperion Therapeutics, INC. $41.29 2020-2021
Arbor Pharmaceuticals, INC. $39.55 2021
Abbott Laboratories $35.04 2021-2023 Freestyle Libre 3
Biohaven Pharmaceutical Holding Company LTD. $32.14 2022
Sanofi Pasteur INC. $29.45 2019-2023
Almatica Pharma LLC $28.93 2022
Novartis Pharmaceuticals Corporation $27.30 2021
Sanofi-Aventis U.S. LLC $26.41 2019-2020
Currax Pharmaceuticals LLC $17.51 2023 Contrave
Kowa Pharmaceuticals America, INC. $16.76 2025 Zoryve
Indivior INC. $16.37 2025 Sublocade
Idorsia Pharmaceuticals US INC $15.81 2022
Lupin INC. $14.99 2019
Janssen Pharmaceuticals, INC $14.88 2020
Vbi Vaccine (Delaware) INC. $14.75 2022
Gilead Sciences, INC. $14.58 2022
Mylan Specialty L.P. $13.98 2019
Xeris Pharmaceuticals, INC. $13.75 2023 Gvoke Hypopen
Evofem Biosciences, INC. $13.63 2022
Shire North American Group INC $12.93 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Deborah A Lozito

$2,950.49

in general payments reported 2019-2025

Years
2019-2025
Top company
Novo Nordisk INC
Context
The $292 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/323368/deborah-a-lozito

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.